English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Page 1 from 134 results
Methods of treating obesity by administering a TAT peptide
Only registered users can translate articles
Log In/Sign up
BACKGROUND
1. Field of the Invention
The present invention relates to a composition for preventing, alleviating or treating obesity comprising partial fragments of Tat (Trans activator of transcription).
2. Background of Technique
Wasting is a major cause of morbidity and mortality associated with
Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
This invention relates to the treatment and prevention of diseases associated with obsessional behaviors such as anorexia, bulimia and addiction to drugs of abuse, associated or not with stress as well as the treatment and prevention of obesity. The invention relates more
Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
This invention relates to the treatment and prevention of diseases associated with obsessional behaviors such as anorexia, bulimia and addiction to drugs of abuse, associated or not with stress as well as the treatment and prevention of obesity. The invention relates more
Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
This invention relates to the treatment and prevention of diseases associated with obsessional behaviors such as anorexia, bulimia and addiction to drugs of abuse, associated or not with stress as well as the treatment and prevention of obesity. The invention relates more
LSR receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
Only registered users can translate articles
Log In/Sign up
INTRODUCTION
The present invention relates to a new complex receptor polypeptide LSR (Lipolysis Stimulated Receptor), characterized by its functional activities, the cloning of the cDNAs complementary to the messenger RNAs encoding each of the subunits of the multimeric complex, vectors and
Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexia
Only registered users can translate articles
Log In/Sign up
1. INTRODUCTION
The present invention relates to the discovery, identification and characterization of nucleotides that encode Ob receptor (ObR), a receptor protein that participates in mammalian body weight regulation. The invention encompasses obR nucleotides, host cell expression systems, ObR
Methods for detection of the Ob receptor and the diagnosis of body weight disorders, including obesity and cachexia
Only registered users can translate articles
Log In/Sign up
1. INTRODUCTION
The present invention relates to the discovery, identification and characterization of nucleotides that encode Ob receptor (ObR), a receptor protein that participates in mammalian body weight regulation. The invention encompasses obR nucleotides, host cell expression systems, ObR
LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
Only registered users can translate articles
Log In/Sign up
INTRODUCTION
The present invention relates to a new complex receptor polypeptide LSR (Lipolysis Stimulated Receptor), characterized by its functional activities, the cloning of the cDNAs complementary to the messenger RNAs encoding each of the subunits of the multimeric complex, vectors and
2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide Y5 (NPY5) ligands for the treatment of obesity
Only registered users can translate articles
Log In/Sign up
The present invention relates to 1,4-disubstituted piperidine compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans or animals.
Neuropeptide Y (NPY), first isolated
Method of screening preventives or remedies for obesity
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention relates to a method of screening drugs (appetite (eating) stimulants, antiobesity drugs, etc.) using a receptor and a polypeptide capable of specifically binding to the receptor, compounds obtainable by the screening method, and the like.
BACKGROUND
Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity
Only registered users can translate articles
Log In/Sign up
1. INTRODUCTION
The present invention relates to mammalian mahogany genes, including the human mahogany gene, which are novel genes involved in the control of mammalian body weight. The invention encompasses nucleotide sequences of the mahogany gene, host cell expression systems of the mahogany
Methods and composition for the diagnosis and treatment of body weight disorders, including obesity
Only registered users can translate articles
Log In/Sign up
1. INTRODUCTION
The present invention relates to mammalian mahogany genes, including the human mahogany gene, which are novel genes involved in the control of mammalian body weight. The invention encompasses nucleotide sequences of the mahogany gene, host cell expression systems of the mahogany
Compositions and methods for the diagnosis and treatment of body weight disorders, including obesity
Only registered users can translate articles
Log In/Sign up
1. INTRODUCTION
The present invention relates to mammalian mahogany genes, including the human mahogany gene, which are novel genes involved in the control of mammalian body weight. The invention encompasses nucleotide sequences of the mahogany gene, host cell expression systems of the mahogany
Screening methods for compounds useful in the regulation of body weight
Only registered users can translate articles
Log In/Sign up
1. INTRODUCTION
The present invention relates to drug screening assays, and diagnostic and therapeutic methods for the treatment of body weight disorders, such as obesity, anorexia and cachexia, involving the melanocortin 4-receptor (MC4-R). The invention also relates to compounds that modulate the
Screening methods for compounds useful in the regulation of body weight
Only registered users can translate articles
Log In/Sign up
TABLE OF CONTENTS
1. INTRODUCTION
2. BACKGROUND OF THE INVENTION
2.1. THE MELANOCORTIN RECEPTORS
2.2. THE AGOUTI PROTEIN
3. SUMMARY OF THE INVENTION
3.1. DEFINITIONS
4. DESCRIPTION OF THE FIGURES
5. DETAILED DESCRIPTION OF THE INVENTION
5.1. THE ROLE OF MC4-R IN THE REGULATION OF BODY WEIGHT
5.2.
The most complete medicinal herbs database backed by science
- Works in 55 languages
- Herbal cures backed by science
- Herbs recognition by image
- Interactive GPS map - tag herbs on location (coming soon)
- Read scientific publications related to your search
- Search medicinal herbs by their effects
- Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research
